Concepedia

Robert Maykut

RM

Statistics

Publications

13

Citations

1.1K

H-Index

13

Active since

2008

Affiliations

Novartis (Switzerland)(Current)

Novartis (United Kingdom)

Novartis (United States)

University of Colorado Denver

National Jewish Health

Robert Maykut is an author at Novartis (Switzerland) specializing in pharmacotherapy, asthma management, and allergy pharmacotherapy.

Publications per year

2008–2018

13

Publications

13

Treatment of chronic autoimmune urticaria with omalizumab

Allen P. Kaplan, Kusumam Joseph, Robert Maykut et al. · Journal of Allergy and Clinical Immunology · 2008 · 285 citations

Life Sciences, Dermatology, Pharmacotherapy +12

The eXpeRience registry: The ‘real-world’ effectiveness of omalizumab in allergic asthma

Gert‐Jan Braunstahl, C.-W. Chen, Robert Maykut et al. · Respiratory Medicine · 2013 · 196 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +14

Persistency of response to omalizumab therapy in severe allergic (IgE-mediated) asthma

Jean Bousquet, Zenon Siergiejko, Ewa Świebocka et al. · Allergy · 2011 · 167 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +16

Uncontrolled asthma: assessing quality of life and productivity of children and their caregivers using a cross-sectional Internet-based survey

Bonnie B. Dean, Brian C. Calimlim, Patricia Sacco et al. · Health and Quality of Life Outcomes · 2010 · 112 citations · Full text

Pharmacy, Child Health, Pediatrics +15

Oral corticosteroid sparing with omalizumab in severe allergic (IgE-mediated) asthma patients

Zenon Siergiejko, Ewa Świebocka, Nicola J. Smith et al. · Current Medical Research and Opinion · 2011 · 88 citations

Life Sciences, Immunology, Pharmacotherapy +17

1–5 of 13